Arca biopharma announces completion of merger with oruka therapeutics and implementation of reverse stock split

The combined company will operate as “oruka therapeutics, inc.” with its common stock traded on nasdaq under trading symbol “orka” effective tuesday, september 3, 2024 the combined company will operate as “oruka therapeutics, inc.” with its common stock traded on nasdaq under trading symbol “orka” effective tuesday, september 3, 2024
ABIO Ratings Summary
ABIO Quant Ranking